Drug Regulation

SpicyIP Weekly Review (March 6- March 11)

Here are the quick summaries of 5 posts, 4 case summaries and other IP developments that took place last week. Important IP cases that we’re missing out on? Especially from other High Courts?  Please let us know so we can include them!   Highlights of the Week Learning from India’s Disastrous Experience in Protecting Itself against Biopiracy In light of the upcoming WIPO Diplomatic Conference on Genetic Resources and Traditional Knowledge, Prashant Reddy brings us a post highlighting India’s sub-par experience with …

SpicyIP Weekly Review (March 6- March 11) Read More »

SpicyIP Tidbit: Delhi HC passes ex parte injunction in favour of Glenmark in ‘TELMA / TELMA-AM’ counterfeiting claim

The Delhi High Court passed an ex parte injunction in the matter of Glenmark Pharmaceuticals vs Sanjeevni Medicos And Or against the defendant and restrained them from manufacturing, marketing, selling, and advertising medicinal and pharmaceutical preparations under Glenmark’s trade mark – ‘TELMA’ and ‘TELMA-AM’ and any other mark deceptively similar to the same. The injunction was granted to prevent confusion or deception amounting to infringement or passing off of Glenmark’s trade mark registrations. Telma and Telma-AM are trademarked names for …

SpicyIP Tidbit: Delhi HC passes ex parte injunction in favour of Glenmark in ‘TELMA / TELMA-AM’ counterfeiting claim Read More »

SpicyIP Weekly Review (January 10- January 16)

After another busy week here at SpicyIP, we bring out the quick summaries of the 6 blogposts that were put up, along with 12 case summaries and national and international IP developments for you. Important IP cases that we’re missing out on? Especially from other High Courts? Please let us know so we can include them!   Highlights of the Week Bill to Decriminalise IP Offences Misses the Mark and Dilutes Significant Provisions Discussing the proposed amendments to the IP …

SpicyIP Weekly Review (January 10- January 16) Read More »

Indian government denies access to Covid 19 vaccine collaboration agreements

The Indian government has refused to disclose its collaboration agreements and investments made in developing and procuring India’s Covid 19 vaccine – Covaxin, the Indian mRNA and intranasal vaccine candidates. Despite widespread public interest in these arrangements, the government has consistently rejected Right to Information (RTI) applications requesting this information. (for the responses received from the CIC see here, here and here) Prashant Reddy (who needs no introduction on this blog) filed several RTI requests covering public-private partnership arrangements related …

Indian government denies access to Covid 19 vaccine collaboration agreements Read More »

SpicyIP Weekly Review (January 02- January 09)

After an eventful first week of the year, we bring out quick summaries of the 6 blogposts we carried, along with 10 cases and other national and international IP developments for you. Important IP cases that we’re missing out on? Especially from other High Courts? Please let us know so we can include them!   Highlights of the Week A Look Back at India’s Top IP Developments of 2022 Continuing with our annual tradition, we curated a list of the …

SpicyIP Weekly Review (January 02- January 09) Read More »

SpicyIP Weekly Review (December 27- January 01)

Wishing our readers a very happy and healthy new year up ahead! The past week, much like the past year was full of interesting IP developments. In this weekly review, we’ll summarize the 4 posts covered on the blog, 7 orders and judgments from the different courts along with a few national and international IP developments. Important IP cases that we’re missing out on? Especially from other High Courts? Please let us know so we can include them! Highlights of …

SpicyIP Weekly Review (December 27- January 01) Read More »

SpicyIP Weekly Review (December 20- December 26)

Happy holidays to all our readers! After another eventful week on the blog, we are here with our weekly reviews summarizing the 5 posts covered on the blog along with 19 case summaries and other national and international IP developments.   Highlights of the Week IP Reveries: Class 5.2 – Interrogating India’s Drug Regulation System Prof. Antilegend and his class are back! This time the discussion ventures further into the Indian drug regulatory system and the class learns more about …

SpicyIP Weekly Review (December 20- December 26) Read More »

IP Reveries: Class 5.2 – Interrogating India’s Drug Regulation System

Prof Antilegend is back to greet you all on this yuletide! After brooding over the basics in the last class, this session (i.e. class 5.2) sieves through the Indian drug regulation system, which has attracted much attention in the last few months. For the previous class, please go here. And if this is your first time coming across the IP Reveries series, you can see what it is about as well as get links to our previous classes in the …

IP Reveries: Class 5.2 – Interrogating India’s Drug Regulation System Read More »

SpicyIP Weekly Review (December 6- December 12)

In addition to the usual round up of our own blog posts in the last week, we also bring to you 20 case summaries and other important national and international IP developments this week. We’re also asking for your help! Important IP cases that we’re missing out on? Especially from other High Courts? Please let us know so we can include them! Additionally, we’ve run this format for weekly reviews for a few weeks now. Do you like it? Hate …

SpicyIP Weekly Review (December 6- December 12) Read More »

Spicy IP Weekly Review (November 22- November 28)

It’s been another IP heavy week for the Indian IP landscape! Here is the last week’s review, discussing the 5 posts published on the blog along with summaries of 16 IP cases from Delhi High Court and a few national and international IP developments. (Important IP cases that we’re missing out on? Especially from other High Courts? Please let us know so we can include them!)   Highlights of the Week Copyright and Classical Music: Not the Best Fusion? Akshat …

Spicy IP Weekly Review (November 22- November 28) Read More »

Scroll to Top